Stevanato Group to Present at the Bank of America Securities Healthcare Conference
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
Stevanato Group appoints Ugo Gay as Chief Operations Officer
Stevanato Group Announces Closing of Upsized PO of Ordinary Shares
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
Stevanato Group Announces Public Offering of Ordinary Shares
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference